New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Eliem Therapeutics, Inc.
ELYM
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

343M

Biotechnology

5.11USD

Shape-0.05 ( -0.97%)
Market Closed (as of Oct 02, 20:00 EDT)
favorite-chart

Relative Strenght

81
favorite-chart

Volume Buzz

54%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

56%

Quote Panel

Shape
Updated February 7, 2025
1W % 1M % 3M % 1Y 56.87 %

Key Metrics

Shape
  • Market Cap

    342.68M


  • Shares Outstanding

    67.06M


  • Share in Float

    26.24M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    5.11


  • Average Volume

    519722


  • Beta

    -0.382


  • Range

    2.35-11.55


  • Industry

    Biotechnology


  • Website

    https://www.eliemtx.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ELYM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.52
vs -3.11

Q3.22

arrow
arrow

N/A

-0.37
vs -0.70

Q4.22

arrow
arrow

N/A

-0.29
vs -0.40

Q1.23

arrow
arrow

N/A

-0.84
vs -0.50

Q2.23

arrow
arrow

N/A

-0.19
vs -0.52

Q3.23

arrow
arrow

N/A

-0.15
vs -0.37

Q4.23

arrow
arrow

N/A

-0.13
vs -0.29

Q1.24

arrow
arrow

N/A

-0.06
vs -0.84

Q2.24

arrow
arrow

N/A

-1.81
vs -0.19

Q3.24

arrow
arrow

+1128%

1.54
vs -0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-up

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

20

20
vs 20

NA

Q1.23

arrow
arrow

19

19
vs 20

-5%

Q2.23

arrow
arrow

21

21
vs 19

11%

Q3.23

arrow
arrow

22

22
vs 21

5%

Q4.23

arrow
arrow

22

22
vs 22

NA

Q1.24

arrow
arrow

20

20
vs 22

-9%

Q2.24

arrow
arrow

47

47
vs 20

135%

Q3.24

arrow
arrow

70

70
vs 47

49%

Earnings Growth

Latest News